M. Tzimas

发表

Association between leukotriene B4-induced phospholipase D activation and degranulation of human neutrophils.

H. Sarau, J. Foley, T. Torphy, 1993, Biochemical pharmacology.

Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli.

P. Young, S. Kumar, D. Griswold, 1997, Biochemical and biophysical research communications.

In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.

H. Sarau, J. Foley, S. Van Horn, 1999, Prostaglandins, leukotrienes, and essential fatty acids.

Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family*

M. Doyle, R. Tal-Singer, P. Young, 2000, The Journal of Biological Chemistry.

Leukotriene D4 Increases the Metabolism of an Inositol Tetrakisphosphate - Containing Phospholipid in U937 Cells

H. Sarau, J. Foley, S. Crooke, 1990 .

Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke.

H. Sarau, J. Foley, F. Barone, 1995, Molecular and chemical neuropathology.

Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea.

J. Adams, R. Garigipati, L. A. Yodis, 1996, Journal of medicinal chemistry.

Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4.

D. Griswold, E. Webb, S. J. Newsholme, 1998, The Journal of investigative dermatology.

(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist.

H. Sarau, J. Foley, D. R. Jakas, 1993, Journal of Medicinal Chemistry.

SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.

H. Sarau, J. Foley, D. Schmidt, 1995, Advances in prostaglandin, thromboxane, and leukotriene research.